ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Trends and Developments in HIV Research Neeta Ratanghayra
March 30, 2022Novel treatment strategies and advances in care have transformed the lives of people living with HIV (human immunodeficiency virus). Antiretroviral therapy (ART), once-daily single-tablet regimens (STRs)... -
Gilead's Truvada for PrEP can reduce HIV rates, but activists decry unequal access
fiercepharma
July 26, 2018Groups around the world are working hard to develop HIV vaccines, but in the meantime, Gilead Sciences reports that Truvada can significantly reduce the rate of new infections when used as a pre-exposure prophylaxis.
Pharma Sources Insight January 2025
